Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Fitusiran prophylaxis in male participants aged 1 to less than 12 years with Hemophilia A or B. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Fitusiran (fitusiran)

Snippet

Sponsor: Sanofi | Conditions: Hemophilia | Phase 3 | Status: RECRUITING